GlassScriptPhysician profile
Thomas W Adler
NPI 1558073528
$2,102.23
in general payments reported to CMS, 2019-2025
27 companies · $643 in 2025
The $643 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,020 · 2024: $439 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,818 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,818.25 |
| Education | $283.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $337.84 | 2023-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $318.80 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $226.47 | 2023-2024 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $205.15 | 2023-2025 | Provenge |
| Olympus America INC. | $174.19 | 2023-2025 | Itind System |
| Abbvie INC. | $126.93 | 2023-2025 | Lupron Depot, Botox |
| Pfizer INC. | $104.97 | 2023 | |
| Astellas Pharma US INC | $95.17 | 2023-2025 | Xtandi |
| Merck Sharp & Dohme LLC | $56.98 | 2023-2025 | Lynparza, Keytruda, Welireg |
| Blue Earth Diagnostics | $52.83 | 2023-2024 | |
| Amgen INC. | $39.16 | 2023 | Prolia |
| Teleflex LLC | $38.89 | 2023 | Urolift |
| Edap Technomed INC | $36.81 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.87 | 2023 | |
| 180 Medical, INC. | $25.84 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $23.61 | 2024 | |
| Tolmar, INC. | $22.83 | 2025 | Jatenzo, Eligard |
| Endo Pharmaceuticals INC. | $22.26 | 2024 | Aveed, Xiaflex |
| Coloplast Corp | $21.38 | 2025 | |
| Boston Scientific Corporation | $20.88 | 2025 | Ams 800 Artificial Urinary Sphincter |
| Vertex Pharmaceuticals Incorporated | $20.64 | 2025 | |
| Progenics Pharmaceuticals, INC. | $18.83 | 2025 | |
| Axonics, INC. | $17.22 | 2023 | Axonics |
| Koelis INC. | $15.65 | 2024 | |
| Convatec INC. | $14.77 | 2023 | |
| Halozyme INC | $14.24 | 2023 | |
| Accord Healthcare, INC. | $14.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.